Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-013560
Filing Date
2023-04-27
Accepted
2023-04-27 16:01:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2023defa14a.htm DEFA14A 24904
2 image_0.jpg GRAPHIC 41860
3 img01_pagex1.jpg GRAPHIC 1410821
4 img01_pagex2.jpg GRAPHIC 673910
  Complete submission text file 0001628280-23-013560.txt   2952810
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35558 | Film No.: 23856618
SIC: 2836 Biological Products, (No Diagnostic Substances)